Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.
Uotani K, Tazawa H, Hasei J, Fujiwara T, Yoshida A, Yamakawa Y, Omori T, Sugiu K, Komatsubara T, Kondo H, Morita T, Kiyono M, Yokoo S, Hata T, Kunisada T, Takeda K, Urata Y, Fujiwara T, Ozaki T.
Uotani K, et al. Among authors: hasei j.
PLoS One. 2024 Feb 20;19(2):e0298292. doi: 10.1371/journal.pone.0298292. eCollection 2024.
PLoS One. 2024.
PMID: 38377118
Free PMC article.